Targeting Metastatic Prostate Cancer
Men with metastatic, castrate-resistant prostate cancer with mutations in genes linked to DNA repair responded to an investigational targeted therapeutic.
Progress Against Cancer
Men with metastatic, castrate-resistant prostate cancer with mutations in genes linked to DNA repair responded to an investigational targeted therapeutic.
A small, early-phase trial of an investigational cancer immunotherapy yielded "durable responses" for patients with advanced melanoma and ocular melanoma.
Trial data first presented at the AACR Annual Meeting 2014, showed drug doubled progression-free survival for a certain type of metastatic breast cancer.
Research is beginning to reveal that the metabolic health problems often associated with being or obese can themselves influence risk for certain cancers.
Drinking about four cups of coffee a day appears to reduce the risk of developing endometrial cancer, a British study reports. Women who drank about four cups of coffee per day appeared to have...
A new study finds that physical activity lowers the likelihood of death in men with localized prostate cancer. Physical activity significantly lowers the risk of death from prostate cancer that has not spread from...
Lowering dietary fat intake reduced death rates in a subgroup of women with breast cancer who were part of the Women’s Intervention Nutrition Study (WINS). You know your diet is an important component of...
The promise and potential of immunotherapy to treat advanced cancers is generating excitement throughout the cancer research and cancer care community.
Despite research-driven progress against breast cancer for many, outcomes vary among women of different races and ethnicities.
Being overweight or obese increases the risk for certain cancers and complications from the treatment of cancer.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More